P0932
Protein A-Agarose from Staphylococcus aureus
lyophilized powder
Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
UNSPSC Code:
41106500
MDL number:
Form:
lyophilized powder
form
lyophilized powder
Quality Level
matrix
Immobilized on 4% cross-linked beaded agarose
matrix activation
p-nitrophenyl chloroformate
matrix attachment
amino
matrix spacer
1 atom
capacity
30-40 mg/mL binding capacity (human IgG)
storage temp.
−20°C
Application
Protein A-agarose is used for affinity chromatography, antibody purification and characterization, and protein A, G and L resins. Protein A-agarose has been used to study the effects of protein A immunoadsorption in patients with chronic dilated cardiomyopathy as well as to study multiple sclerosis and gastric cancer.
Physical form
Supplied as lyophilized powder stabilized with lactose.
Preparation Note
Swelling: 1 g swells to approx. 4 ml.
Still not finding the right product?
Explore all of our products under Protein A-Agarose from Staphylococcus aureus
Storage Class
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves, type N95 (US)
Regulatory Information
常规特殊物品
This item has
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Related Content
Instructions
Guoxin Shen et al.
The Plant journal : for cell and molecular biology, 49(2), 228-237 (2007-01-24)
Animal CHIP proteins are chaperone-dependent E3 ubiquitin ligases that physically interact with Hsp70, Hsp90 and proteasome, promoting degradation of a selective group of non-native or damaged proteins in animal cells. The plant CHIP-like protein, AtCHIP, also plays important roles in
Xiaohong Shi et al.
Methods in molecular biology (Clifton, N.J.), 379, 137-148 (2007-05-16)
The membrane glycoproteins (Gn and Gc) of viruses in the family Bunyaviridae form projections on the virion envelope and are involved in virus entry and eliciting protective immunity. The glycoproteins are modified by N-linked glycosylation and accumulate in the Golgi
Laurent Garderet et al.
Leukemia & lymphoma, 47(7), 1340-1347 (2006-08-23)
This study evaluated the feasibility of using dendritic cells (DCs) to generate, ex vivo, anti-tumor cytotoxic T lymphocytes (CTL) in patients with stage III multiple myeloma (MM). Nucleated cells from eight patients who had received chemotherapy (three of whom had
Global Trade Item Number
| SKU | GTIN |
|---|---|
| P0932-250MG | 04061834353362 |
| P0932-1G | 04061834353355 |